A team of investigators has made key new findings about an extremely rare childhood cancer called neurocutaneous melanocytosis. This malignant cancer is characterized by an excessive growth of melanin-producing cells in both the skin and the brain. The study’s authors found potential drug targets for the disease by using a molecular analysis of patient tumor cells grown in animal models.